RECRUITING

Blood Flow Restriction Therapy in Achilles Injury

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Blood flow restriction (BFR) therapy is a brief and partial restriction of venous outflow of an extremity during low load resistance exercises. It is a safe and effective method of improving strength in healthy and active individuals, recovering from orthopedic pathologies and procedures. This prospective, randomized study will look at the implications this form of treatment has on the rehabilitation of Achilles injuries.

Official Title

Blood Flow Restriction Therapy in Achilles Injury

Quick Facts

Study Start:2021-10-08
Study Completion:2025-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04104126

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosed with Achilles Injury
  2. * Must be at least 18 years of age and younger than 65 years of age
  3. * Intention to receive physical therapy as standard of care
  1. * Patients with intention to receive standard therapy and not the study therapy
  2. * Patients with impaired circulation, peripheral vascular compromise, previous revascularization of the extremity, or severe hypertension
  3. * Younger than 18 years of age or older than 65
  4. * Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)
  5. * Any patient considered a vulnerable subject

Contacts and Locations

Study Contact

Larry Chen
CONTACT
(317)847-1784
Larry.Chen@nyulangone.org
Michael Moore
CONTACT
347-554-0183
michael.moore@nyulangone.org

Principal Investigator

Guillem Gonzalez-Lomas, MD
PRINCIPAL_INVESTIGATOR
New York Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10017
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Guillem Gonzalez-Lomas, MD, PRINCIPAL_INVESTIGATOR, New York Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-10-08
Study Completion Date2025-04

Study Record Updates

Study Start Date2021-10-08
Study Completion Date2025-04

Terms related to this study

Additional Relevant MeSH Terms

  • Achilles Injuries Tendon